Current Report Filing (8-k)
April 26 2016 - 4:26PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 26, 2016
NUVASIVE, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
000-50744
|
|
33-0768598
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
7475 Lusk Boulevard, San Diego, California 92121
(Address of principal executive offices) (Zip Code)
(858) 909-1800
(Registrants telephone number, including area code)
n/a
(Former name or
former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02
|
Results of Operations and Financial Condition.
|
On April 26, 2016, NuVasive, Inc.
(the Company) issued a press release announcing its financial results for the quarter ended March 31, 2016. A copy of this press release is furnished as Exhibit 99.1 to this Current Report.
Item 7.01
|
Regulation FD Disclosure.
|
During a conference call scheduled to be held at 1:30 p.m.
Pacific Time on April 26, 2016, the Companys Chairman and Chief Executive Officer and Chief Financial Officer will discuss the Companys results for the quarter ended March 31, 2016 and the Companys outlook for the year
ending December 31, 2016. The slide presentation for the conference call is furnished as Exhibit 99.2 to this Current Report.
The
information contained in this Current Report and the Exhibits hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01
|
Financial Statements and Exhibits.
|
|
|
|
99.1
|
|
Press release issued by NuVasive, Inc. on April 26, 2016
|
|
|
99.2
|
|
Slide presentation
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
NUVASIVE, INC.
|
|
|
By:
|
|
/s/ Jason D. Hanson
|
|
|
Jason D. Hanson
|
|
|
Executive Vice President, Strategy, Corporate Development and General Counsel
|
Date: April 26, 2016
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press release issued by NuVasive, Inc. on April 26, 2016
|
|
|
99.2
|
|
Slide presentation
|
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Apr 2023 to Apr 2024